Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
Batinac, T., Hlača, N., Simetić, L., Valković, F., Peternel, S. i Prpić Massari, L. (2022). Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma. Acta Dermato-Venereologica, 102.. doi: 10.2340/actadv.v102.1433
Batinac, Tanja, et al. "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma." Acta Dermato-Venereologica, vol. 102, 2022. https://doi.org/10.2340/actadv.v102.1433
Batinac, Tanja, Nika Hlača, Luka Simetić, Frane Valković, Sandra Peternel i Larisa Prpić Massari. "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma." Acta Dermato-Venereologica 102 (2022). https://doi.org/10.2340/actadv.v102.1433
Batinac, T., et al. (2022) 'Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma', Acta Dermato-Venereologica, 102. doi: 10.2340/actadv.v102.1433
Batinac T, Hlača N, Simetić L, Valković F, Peternel S, Prpić Massari L. Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma. Acta Dermato-Venereologica [Internet]. 22.02.2022. [pristupljeno 19.11.2024.];102. doi: 10.2340/actadv.v102.1433
T. Batinac, N. Hlača, L. Simetić, F. Valković, S. Peternel i L. Prpić Massari, "Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma", Acta Dermato-Venereologica, vol. 102, Veljača 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:920000. [Citirano: 19.11.2024.]